Nippon India Pharma Fund - IDCW Option
(Erstwhile Reliance Pharma Fund-Dividend Plan)
Fund House: Nippon India Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-06-2004 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| TER: 1.82% As on (30-04-2024) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 7,132.82 Cr As on (30-04-2024) |
| Turn over: 14% | Exit Load: Exit load of 1% if redeemed within 1 month. |
110.1592
0.58 (0.5301%)
20.0%
Benchmark: 14.78%
PERFORMANCE
Returns Type:
of :
Start :
End :
Period:
This Scheme
-
vs
NIFTY 50 TRI
-
Gold
-
PPF
-
Returns Type:
of :
Period:
Start :
Period:
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Time Taken To Multiply
2x
4x
5x
10x
FUND
1 Years 11 Months
6 Years 1 Months
9 Years 6 Months
19 Years 5 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Current Asset Allocation (%)
Indicators
| Standard Deviation | |
| Sharpe Ratio | 0.32 |
| Alpha | 1.92 |
| Beta | 0.97 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
19.87%
Others
3.83%
Large Cap
40.36%
Mid Cap
35.94%
